BioMed Research International
Volume 2018 (2018), Article ID 7392435, 5 pages
https://doi.org/10.1155/2018/7392435

Research Article

Impact of Thoracoscopic Pulmonary Vein Isolation on Right Ventricular Function: A Pilot Study

Gijs E. De Maat,¹ Yoran M. Hummel,² Alberto Pozzoli,³ Ottavio R. Alfieri,³ Michiel Rienstra,² Yuri Blaauw,² Isabelle C. Van Gelder,² and Massimo A. Mariani¹

¹Department of Cardiothoracic Surgery and Cardiology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB Groningen, Netherlands
²Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
³Heart Surgery Unit, San Raffaele University Hospital, Milan, Italy

Correspondence should be addressed to Gijs E. De Maat; g.e.de.maat@umcg.nl

Received 30 July 2017; Revised 9 January 2018; Accepted 22 January 2018; Published 20 February 2018

Academic Editor: Christof Kolb

Copyright © 2018 Gijs E. De Maat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objective. Thoracoscopic surgical pulmonary vein isolation (sPVI) has been added to the treatment of atrial fibrillation (AF), showing excellent efficacy outcomes. However, data on right ventricular (RV) function following sPVI has never been studied. Our aim was to investigate RV function following sPVI and compare it to patients who underwent endocardial cryoballoon PVI. Methods. 25 patients underwent sPVI and were pair-matched according to age, sex, and AF type with 21 patients who underwent cryoballoon PVI. RV function was measured using tricuspid annular plane systolic excursion (TAPSE) and RV strain with 2D speckle tracking. Echocardiography was performed at baseline and at median 6-month follow-up. Results. Age was 54 ± 9 years and 84% were male; AF was paroxysmal in 92%. In the sPVI group, TAPSE was reduced with 31% at follow-up echocardiography and RV strain showed a 25% reduction compared to baseline . In the control group, TAPSE and RV strain did not change significantly (−3% and +13%, and ). Change in TAPSE and RV strain was significantly different between groups ( and ). Conclusions. This study shows that RV function is significantly decreased following sPVI. This effect was not observed in the cryoballoon PVI control group.

1. Introduction

In the recent years, thoracoscopic surgical pulmonary vein isolation (sPVI) has been added to the treatment of atrial fibrillation (AF). This technique has been shown to be safe and numerous studies have shown excellent efficacy outcome in paroxysmal and short-standing persistent AF due to high transmurality yielded epicardially by bipolar radiofrequency devices [1, 2]. However, right ventricular (RV) function following sPVI has not been investigated. The occurrence of RV dysfunction is not easily predictable and is often unexpected. However, RV function is a major determinant of clinical outcomes following cardiac surgery [3]. With the development of speckle tracking echocardiography, assessment of the RV has become more accessible and reliable for routine clinical practice [4]. The aim of this study was to investigate the right ventricular (RV) function in patients who underwent sPVI and compare it to cryoballoon PVI outcomes.

2. Materials and Methods

We studied a series of patients who underwent sPVI as a first PVI procedure during the period of 2009–2011 in our university medical center. Inclusion criteria were highly symptomatic paroxysmal or early persistent AF, without concomitant cardiac structural disease, refractory to class I and/or class III antiarrhythmic drugs [2]. Exclusion criteria for surgical PVI were left atrial size > 55 mm (parasternal view), prior transcatheter PVI, prior heart or lung surgery, significant coronary disease or previous myocardial infarction, left ventricle hypertrophy > 12 mm, previous hospitalization for heart failure, left ventricular dysfunction (ejection fraction < 50%), moderate or severe mitral or aortic valve disease, or lung disease (prior tuberculosis or chronic obstructive pulmonary disease, GOLD classes III-IV). The control group consisted of patients with the same indication who underwent cryoballoon PVI in the same period, also as first invasive procedure. Patients who underwent sPVI were pair-matched retrospectively according to age, sex, and AF type with patients who underwent cryoballoon PVI. All sPVI patients were treated using the video-assisted bilateral thoracoscopy. To isolate the pulmonary veins, a bipolar radiofrequency clamp (Isolator, AtriCure, Cincinnati, Ohio, USA) was used to create linear, thermal lesions. Following the ablation, exit block was confirmed, no additional linear ablation lines were applied, and the left atrial appendage was not excluded [1, 2]. The lateral incision of the pericardium was not routinely closed after completion of the lesion set. The control group consisted of patients who underwent endocardial PVI using the second-generation cryoballoon (Arctic Front Advance™, Medtronic CryoCath LP, Pointe-Claire, Canada). Following ablation, antiarrhythmic drugs were continued during the first three months. Patients underwent a standardized transthoracic echocardiogram preoperatively and at 6-month (range: 3–12) follow-up. Offline analyses were performed by an expert sonographer (Yoran M. Hummel) who was blinded with respect to treatment type. All measurements were performed using EchoPAC BT12, following the 2015 recommendations of the American Society of Echocardiography [5]. RV function was measured using tricuspid annular plane systolic excursion (TAPSE-M-mode) and RV longitudinal deformation (strain) with 2D speckle tracking; in an apical four-chamber view, the edge of the RV endocardium was manually traced, after which the software automatically generated tracings. The basal, middle, and apical segments of the RV were traced. In the analysis, a mean strain of these three segments was calculated. To reliably measure RV function, patients with AF or atrial flutter during echocardiography were excluded from the analysis.

2.1. Statistics

Baseline descriptive statistics are presented as mean ± standard deviation or median (range) for continuous variables, as appropriate, and counts with percentages for categorical variables. Differences between groups, in terms of patient characteristics at baseline and different follow-up moments, were evaluated by Student’s t-test or Mann–Whitney U test, depending on normality of the data. Differences within subgroups were evaluated using the paired t-test. Chi-square or Fisher’s exact test was used for comparison of categorical variables. The statistical software package IBM SPSS Statistics v.22 was used.

3. Results

The sPVI group consisted of 25 patients, mean age was 54 ± 9 years, and 84% were male. AF was paroxysmal in 92% and short term persistent in 8%. The control group consisted of 21 patients with similar characteristics who underwent cryoballoon PVI in the same center and period. Baseline patient characteristics did not differ significantly between groups (Table 1). There was no concomitant structural coronary, heart, or valve disease present at baseline. At baseline, echocardiography parameters were comparable between groups except for RA length, which was larger in the sPVI group (57.8 ± 6.2 versus 52.8 ± 5.1, ), but RA width did not differ between groups (43,7 ± 5,9 versus 41,6 ± 5,1, ). At baseline echocardiography, TAPSE was higher in the sPVI group compared to the cryoballoon group (26,6 ± 4,0 versus 23,9 ± 3,7, ; Table 2). In the sPVI group, RV function measured by TAPSE was significantly reduced with a mean of −8.3 mm (−31%) at median 6-month follow-up echocardiography () (Figure 1(a)). Furthermore, the average RV strain showed a mean change of −5.6 percentage points (−25%) compared to baseline echocardiography () (Figure 1(b)). In the control group, the TAPSE was reduced with a mean of −0.8 mm (−3%) and RV strain increased with 2.7 percent points (+13%); this was not significant ( and , resp.). When the change from baseline to follow-up (delta) measurement in TAPSE and RV strain was compared between the two groups, this showed a significant difference (mean TAPSE −8.3 mm versus −0.8 mm, , and mean RV strain −5.6 percentage points versus +2.7 percentage points, ).

Table 1: Baseline characteristics and echocardiography outcomes.

Baseline patient characteristics

Parameter
sPVI
CRYO
value

Age (years)
54 ± 9
58 ± 7
0.089

Male (, %)
21 (84%)
15 (71%)
0.303

AF history, years [range]
3 [1–14]
4 [1–15]
0.178

Paroxysmal AF (, %)
23 (92%)
17 (81%)
0.268

Short-standing persistent AF (, %)
2 (8%)
4 (19%)

BMI (kg/m²)
27.1 ± 2.9
28.2 ± 3.3
0.251

Systolic BP (mmHg)
132 ± 17
137 ± 16
0.383

Diastolic BP (mmHg)
79 ± 9
83 ± 10
0.234

AF: atrial fibrillation; BMI: body mass index; BP: blood pressure; sPVI: surgical pulmonary vein isolation; TAPSE: tricuspid annular plane systolic excursion.

Table 2: Echocardiography outcomes.

sPVI group echocardiography
CRYO group echocardiography

Parameter
Baseline
Follow-up
value
Baseline
Follow-up
value

LV ejection fraction (%)
60 ± 5
57 ± 5
0.062
60 ± 6
58 ± 7
0.198

LA volume (mm3)
75 ± 19
78,3 ± 23.6
0.674
79 ± 26
71.0 ± 26.0
0.209

LA volume indexed
33,7 ± 6
35,8 ± 10.2
0.430
36.3 ± 11
34.0 ± 12.5
0.414

RA length (mm)
57,8 ±  
57,4 ± 5.3
0.647
52.8 ±  
50.1 ± 5.5
0.048

RA width (mm)
43,7 ± 5.9
43,7 ± 5.1
0.835
41.6 ± 5.1
37.6 ± 5.8
0.035

RVEDD (%)
38,8 ± 5.5
39,0 ± 5.3
0.771
39.6 ± 7.9
37.4 ± 4.5
0.332

TAPSE (mm)
26,6 ±  
18,3 ± 3.8
<0.001
23.9 ±  
23.1 ± 4.5
0.410

RV strain (%)
24.4 ± 3.7
18.8 ± 4.6
0.018
21.0 ± 6.9
23.7 ± 5.2
0.148

LA: left atrial; LV: left ventricular; RA: right atrial; RVEDD: right ventricle end diastolic diameter; sPVI: surgical pulmonary vein isolation; TAPSE: tricuspid annular plane systolic excursion. Significant difference between groups at baseline.

(a) Tricuspid annular plane systolic excursion

(b) Right ventricular strain

Figure 1

3.1. Procedural Outcomes

In all sPVI patients, the procedure was completed with proven acute exit block. Mean procedural time was 160 ± 60 minutes. Mean hospitalization was 7 ± 2 days. There was no 30-day or 1-year mortality. At 12-month follow-up, 88% of sPVI patients were free from atrial arrhythmia and antiarrhythmic drugs. In the cryoballoon group, all patients underwent successful PVI with proven entry and exit block. Mean procedural time was 100 ± 20 minutes. Mean hospitalization was 3 ± 1 days. There was no 30-day or 1-year mortality. At 12-month follow-up, 67% of patients were free from atrial arrhythmia and antiarrhythmic drugs.

4. Discussion

This study shows that RV function is significantly decreased following sPVI during the first year. This effect was not observed in our control group, a similar patient population who underwent cryoballoon PVI. Both study groups underwent echocardiographic analysis preoperatively and at 6-month follow-up; there was no significant valve disease and atria were moderately dilated in both groups without significant differences at baseline, except for RA length, which was larger in the sPVI, but RA width did not differ between groups. In both groups, the left atrium was moderately dilated in concordance with the disease. At baseline, mean TAPSE was significantly higher in the sPVI group compared to the CRYO group. However, at follow-up, this was significantly lower. This effect was objectified by means of RV strain.

Decreased RV function following sPVI has not been described previously. On the other hand, in patients who underwent open-chest CABG (both on and off pump), a reduced RV function has been already documented [6]. Remarkably, a study comparing conventional surgical aortic valve replacement (AVR) to transcatheter AVR demonstrated a similar reduction of RV strain at follow-up in patients who underwent surgery [7]. Although the present analysis does not allow definite conclusions regarding the exact underlying mechanism, the reduction of RV function might be attributable to two factors. First, due to the lateral opening of the pericardium, the mechanical support (restraint) is reduced. The right atrium and right ventricle have relatively limited intrinsic stiffness, compared to the left heart side, and are therefore more dependent on pericardial support [8]. Second, the opening of the pericardium causes an inflammatory reaction, which leads to the formation of adhesions between the pericardium and the epicardium. These adhesions can reduce compliance, especially of thin-walled chambers (RA and RV), and thereby impair ventricular filling. Of course, also a combination of both factors could contribute to a reduced RV function following sPVI. Whether decrease in RV function is permanent is associated with symptoms or even heart failure needs to be determined in future studies. An appropriate understanding of pericardial constraint is required. The observational nature of our study and limited number of patients do not allow definitive conclusions.

In conclusion, this study shows that RV function is significantly decreased following sPVI during the first year. This effect was not observed in a similar patient population that underwent cryoballoon PVI. In accordance with the findings of this study, our operative protocol has changed. The right pericardial incision is now routinely closed with approximating endosutures.

Conflicts of Interest

The authors report no conflicts of interest.

Acknowledgments

The authors thank Dr. Bastiaan Geelhoed for his statistical advice and contribution to the figures.

References

A. Yilmaz, B. P. van Putte, and W. J. van Boven, “Completely thoracoscopic bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation,” The Journal of Thoracic and Cardiovascular Surgery, vol. 136, no. 2, pp. 521-522, 2008.

G. E. de Maat, A. Pozzoli, M. F. Scholten et al., “Surgical minimally invasive pulmonary vein isolation for lone atrial fibrillation: midterm results of a multicenter study,” Innovations : technology and techniques in cardiothoracic and vascular surgery, vol. 8, no. 6, pp. 410–415, 2013.

F. Haddad, R. Doyle, D. J. Murphy, and S. A. Hunt, “Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure,” Circulation, vol. 117, no. 13, pp. 1717–1731, 2008.

L. L. Mertens and M. K. Friedberg, “Imaging the right ventricleg-current state of the art,” Nature Reviews Cardiology, vol. 7, no. 10, pp. 551–563, 2010.

R. M. Lang, L. P. Badano, and V. Mor-Avi, “Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging,” Journal of the American Society of Echocardiography, vol. 28, no. 1, pp. 1.e14–39.e14, 2015.

A. Raina, A. Vaidya, Z. M. Gertz, Susan Chambers, and P. R. Forfia, “Marked changes in right ventricular contractile pattern after cardiothoracic surgery: Implications for post-surgical assessment of right ventricular function,” The Journal of Heart and Lung Transplantation, vol. 32, no. 8, pp. 777–783, 2013.

A. Kempny, G.-P. Diller, G. Kaleschke et al., “Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function,” Heart, vol. 98, no. 17, pp. 1299–1304, 2012.

H. S. Maniar, S. M. Prasad, S. L. Gaynor, C. M. Chu, P. Steendijk, and M. R. Moon, “Impact of pericardial restraint on right atrial mechanics during acute right ventricular pressure load,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 284, no. 1, pp. H350–H357, 2003.